Joe Yoshizawa Selected Research

Joe Yoshizawa Research Topics

2	Heart Arrest (Cardiac Arrest) 09/2020 - 07/2016
2	Post-Cardiac Arrest Syndrome 09/2020 - 07/2016
2	Chronic Renal Insufficiency 09/2017 - 09/2012
1	Hypertension (High Blood Pressure) 11/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2020
1	Coma (Comas) 09/2020
1	Hemorrhagic Shock 01/2020
1	Shock 01/2020
1	Necrosis 01/2020
1	Hemorrhage 01/2020
1	Diabetes Mellitus 09/2017
1	Traumatic Intracranial Hemorrhage 10/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2016
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2016
1	Fatty Liver 01/2016
1	Insulin Resistance 01/2016
1	Neck Pain (Cervicalgia) 01/2016
1	Atherosclerosis 09/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2012

4	HydrogenIBA 11/2020 - 07/2016
2	Triglycerides (Triacylglycerol)IBA 09/2017 - 01/2016
2	Lipoproteins (Lipoprotein)IBA 09/2017 - 09/2012
2	oxidized low density lipoproteinIBA 01/2016 - 09/2012
2	LDL CholesterolIBA 01/2016 - 09/2012
1	Dialysis SolutionsIBA 11/2020
1	Antihypertensive Agents (Antihypertensives)IBA 11/2020
1	CytokinesIBA 09/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	LipidsIBA 09/2017
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 09/2017
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 09/2017
1	AnticoagulantsIBA 10/2016
1	Vitamin K FDA Link 10/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2016
1	AdiponectinIBA 01/2016
1	remnant-like particle cholesterolIBA 01/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2016
1	ApolipoproteinsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	lipoprotein cholesterolIBA 09/2012

2	Renal Dialysis (Hemodialysis) 09/2017 - 09/2012
1	Blood Pressure Monitors 11/2020
1	Resuscitation 01/2020
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2016